Project Grant R01DK149293

Award Summary

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $799,752 to The Research Foundation for the State University of New York (effective July 1, 2026, through June 30, 2031) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds a clinical research study comparing the efficacy of continuous glucose monitoring (CGM) relative to traditional finger-stick self-monitoring of blood glucose (SMBG) in non-insulin-treated adults with poorly controlled Type 2 Diabetes Mellitus (T2DM). The study will randomize approximately 240 participants to three treatment arms: traditional finger-stick SMBG, CGM alone with instructional materials, or CGM combined with tailored health coaching.

The research will evaluate primary clinical outcomes including glycemic control, blood pressure, and lipid control at 12 months and sustainability outcomes at 18 months. Secondary objectives will assess the impact on self-care behaviors (diet, physical activity, and medication adherence) and quality of life, along with cost-effectiveness analyses comparing both CGM interventions to traditional SMBG. This comparative effectiveness study addresses a significant gap in evidence regarding CGM utility for non-insulin-dependent T2DM patients, a population currently excluded from insurance coverage for CGM technology despite clinical evidence supporting its benefits over traditional monitoring methods.